JP2008504237A5 - - Google Patents

Download PDF

Info

Publication number
JP2008504237A5
JP2008504237A5 JP2007516412A JP2007516412A JP2008504237A5 JP 2008504237 A5 JP2008504237 A5 JP 2008504237A5 JP 2007516412 A JP2007516412 A JP 2007516412A JP 2007516412 A JP2007516412 A JP 2007516412A JP 2008504237 A5 JP2008504237 A5 JP 2008504237A5
Authority
JP
Japan
Prior art keywords
amino acid
compound according
compound
group
cyclized
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007516412A
Other languages
English (en)
Japanese (ja)
Other versions
JP5280683B2 (ja
JP2008504237A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/NO2005/000210 external-priority patent/WO2005123768A1/en
Publication of JP2008504237A publication Critical patent/JP2008504237A/ja
Publication of JP2008504237A5 publication Critical patent/JP2008504237A5/ja
Application granted granted Critical
Publication of JP5280683B2 publication Critical patent/JP5280683B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007516412A 2004-06-16 2005-06-15 ペプチド系化合物 Expired - Fee Related JP5280683B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NO20042523 2004-06-16
NO20042523 2004-06-16
PCT/NO2005/000210 WO2005123768A1 (en) 2004-06-16 2005-06-15 Peptide-based compounds

Publications (3)

Publication Number Publication Date
JP2008504237A JP2008504237A (ja) 2008-02-14
JP2008504237A5 true JP2008504237A5 (enExample) 2008-07-31
JP5280683B2 JP5280683B2 (ja) 2013-09-04

Family

ID=34979156

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007516412A Expired - Fee Related JP5280683B2 (ja) 2004-06-16 2005-06-15 ペプチド系化合物

Country Status (10)

Country Link
US (1) US7897142B2 (enExample)
EP (1) EP1765863B1 (enExample)
JP (1) JP5280683B2 (enExample)
CN (2) CN1968963A (enExample)
AT (1) ATE538135T1 (enExample)
BR (1) BRPI0512209A (enExample)
ES (1) ES2376557T3 (enExample)
PL (1) PL1765863T3 (enExample)
RU (1) RU2393167C2 (enExample)
WO (1) WO2005123768A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2719088T3 (es) * 2001-07-10 2019-07-08 Ge Healthcare Ltd Compuestos con base peptídica para localizar receptores de integrina
BRPI0518328A2 (pt) * 2004-11-22 2008-11-11 Ge Healthcare As agente de contraste, composiÇço farmacÊutica, uso de um agente de contraste, mÉtodo para gerar imagens realÇadas de um corpo animal ou humano, e, kit para a preparaÇço de um composiÇço radiofarmacÊutica
ITMI20050328A1 (it) 2005-03-03 2006-09-04 Univ Degli Studi Milano Composti peptidomimetrici e preparazione di derivati biologicamente attivi
GB0718967D0 (en) * 2007-09-28 2007-11-07 Ge Healthcare Ltd Peptide imaging agents
GB0718957D0 (en) * 2007-09-28 2007-11-07 Ge Healthcare Ltd Optical imaging agents
EP3673922A1 (en) 2008-03-14 2020-07-01 VisEn Medical, Inc. Integrin targeting agents and methods of using same
US20100291706A1 (en) * 2009-05-15 2010-11-18 Millipore Corporation Dye conjugates and methods of use
EP2314597B1 (en) * 2009-10-21 2012-11-28 Cyanagen Srl Kit and method for the labelling of biomolecules
CN103052690A (zh) 2010-06-29 2013-04-17 通用电气医疗集团股份有限公司 染料组合物和染料合成
GB201010878D0 (en) 2010-06-29 2010-08-11 Ge Healthcare As Dye compositiion and dye syntheses
US9592307B2 (en) 2012-07-20 2017-03-14 Canon Kabushiki Kaisha Compound and photoacoustic imaging contrast medium containing the compound
WO2014055253A1 (en) * 2012-10-04 2014-04-10 The General Hospital Corporation Methods of synthesizing and using peg-like fluorochromes
WO2015059368A1 (fr) * 2013-09-02 2015-04-30 L'oreal Procede de coloration des fibres keratiniques a partir de colorants cationiques styryles disulfures, et composition comprenant lesdits colorants
CN107022350A (zh) * 2017-04-20 2017-08-08 深圳大学 一种荧光造影材料及其制备方法与应用
CN107739528A (zh) * 2017-09-30 2018-02-27 武汉工程大学 一种五肽改性菁染料化合物及其制备方法和应用
IL287989B2 (en) 2019-05-13 2025-07-01 Bracco Imaging Spa Modified cyanine dyes and their conjugates
EP4137502A4 (en) * 2020-03-30 2024-02-28 Ichimaru Pharcos Co., Ltd. Vipr2 antagonist peptide
EP4267971A4 (en) 2021-04-07 2024-08-07 Becton, Dickinson and Company Water-soluble fluorescent polymeric dyes

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4445065A1 (de) * 1994-12-07 1996-06-13 Diagnostikforschung Inst Verfahren zur In-vivo-Diagnostik mittels NIR-Strahlung
DE19917713A1 (de) * 1999-04-09 2000-10-19 Diagnostikforschung Inst Kurzkettige Peptid-Farbstoffkonjugate als Konstrastmittel für die optische Diagnostik
ATE298763T1 (de) * 2000-04-12 2005-07-15 Amersham Health As Integrinbindende peptidderivate
ES2719088T3 (es) * 2001-07-10 2019-07-08 Ge Healthcare Ltd Compuestos con base peptídica para localizar receptores de integrina
NO20033115D0 (no) 2003-07-08 2003-07-08 Amersham Health As Peptid-baserte forbindelser

Similar Documents

Publication Publication Date Title
JP2008504237A5 (enExample)
JP2007530441A5 (enExample)
JP2016153410A5 (enExample)
JP2003531835A5 (enExample)
CA2452923A1 (en) Peptide-based compounds for targeting integrin receptors
RU2451029C2 (ru) Производное инсулина
JP2010521485A5 (enExample)
JP2020513019A5 (enExample)
JP2022095872A5 (enExample)
JP2009541288A5 (enExample)
JP2019043957A5 (enExample)
JP2014520120A5 (enExample)
JP2010522693A5 (enExample)
RU2006144279A (ru) Пептидные соединения
ATE254630T1 (de) Cyclosporine
RU2019105549A (ru) Гидрофильные саморазрушающиеся линкеры и их конъюгаты
JP2015518832A5 (enExample)
HRP20161677T1 (hr) Pegilirani fab protiv amiloida beta
JP2009535387A5 (enExample)
JP2017529322A5 (enExample)
RU2003137592A (ru) Улучшенные хелатные конъюгаты
RU2019141031A (ru) Соединения на основе MIC-1 и пути их применения
JP2007500222A5 (enExample)
RU2007118385A (ru) Контрастные агенты для направлений доставки во внеклеточный матрикс
JP2020511450A5 (enExample)